PRE-MARKET MOVERS
UPGRADES
3. CHK:$CHK upgraded to Sector Perform at RBC Capital
DOWNGRADES
1. ARIA:$ARIA downgraded to Market Perform at JMP Securities.
8. V:$V downgraded to Neutral at Guggenheim, maintains Buy rating at UBS – PT raise $97 from $90
9. VFC:$VFC downgraded to Hold at Deutsche Bank – PT raise $97 from $90, maintains Buy rating at UBS – PT cut $59 from $65
EARNINGS
Trending Social Alerts
1. MRK:$MRK Merck & Co Q3 16 Earnings Results: -Adj EPS: $1.07 -Revenue: $10.5B
2. UA:Under Armour Reports Q3 EPS $0.29 vs $0.25 Est., Sales $1.472B vs $1.45B Est. $UA
6. UTX:$UTX United Technologies Q3 16 Earnings Results: -Adj EPS: $1.76 -Revenue: $14.4B
9. NVS:Strong indication from Jimenez on conf call that $NVS would love to sell Roche stake to buy bolt-on instead – actively looking
11. DD:#jimcramer $DD raises 2016 operating profit guidance – my RealMoneyPro long standing favorite large cap for 2016
13. DPRX:$DPRX halt
14. PG:P&G Reports Q1 Adj. EPS $1.03 vs $0.98 Est., Sales $16.52B vs $16.5B Est. $PG
15. MMM:$GM crushes numbers, “Automotive Strength” a theme across multiple industry reports including $MMM and $DD today
Trending News Headlines
1. Bear thesis on Corbus Pharma could cause a crash landing for high-flying biotech stock
The market is acting like resunab is a real drug, which is why my investor source is short Corbus.
2. Twitter Planning Hundreds More Job Cuts as Soon as This Week
Twitter Inc. is planning widespread job cuts, to be announced as soon as this week, according to people familiar with the matter.
3. Caterpillar Lowers Sales Forecast as Rebound Proves Elusive
Caterpillar Inc., the biggest maker of construction and mining equipment, cut its 2016 revenue forecast and said next year won’t be much different as companies defer purchases amid sluggish growth and low commodity price expectations. Shares fell.
4. Merck Announces Third-Quarter 2016 Financial Results | Merck Newsroom Home
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2016.
5. Under Armour Tumbles After Forecast Renews Fears of Slowdown
Under Armour Inc. shares fell as much as 18 percent in early trading after its long-term forecast renewed fears that the athletic brand’s growth streak is finally sputtering.
6. New Results Presented for Opdivo (nivolumab) Demonstrate Encouraging Response Rate in an Expanded Population of Heavily Pre-Treated Classical Hodgkin Lymphoma Patients | Business Wire
New Results Presented for Opdivo (nivolumab) Demonstrate Encouraging Response Rate in an Expanded Population of Heavily Pre-Treated Classical Hodgkin
7. Pfizer cuts price of Enbrel to match rival ‘biosimilar’ drug
Price drop is first under pricing deal signed by Government and Irish Pharmaceutical Healthcare Association
8. Syngenta-ChemChina Deal Closing Likely to Be Delayed
Swiss seed and pesticide maker Syngenta said regulatory approval of its proposed acquisition by ChemChina is likely to be delayed into early 2017 as regulators seek more information amid a consolidation wave in the sector.
9. Baker Hughes posts smaller-than-expected loss as cost cuts pay off
Oilfield services provider Baker Hughes Inc (BHI.N) reported a much smaller-than-expected quarterly loss as the company’s aggressive cost-cutting measures paid off.
10. Sheff on Twitter
“$TGTX..$6.23..Key Milestones & $15 PT valuation (Sun)”
11. UPDATE: Chardan Capital Markets Starts Clovis Oncology (CLVS) at ‘Sell’ With Price Target of $15
(Updated – October 25, 2016 8:28 AM EDT) Chardan Capital Markets initiated coverage on Clovis Oncology (NASDAQ: CLVS) with a Sell rating and a price target of $15. Analyst Madhu Kumar doesn’t…
12. Uber’s Otto hauls Budweiser across Colorado in self-driving truck
In the first real-world commercial use of autonomous trucking, some 45,000 cans of Budweiser beer arrived late last week to a warehouse after traveling over 120 highway miles in a self-driving truck with no driver at the wheel, executives from Uber [UBER.UL] and Anheuser-Busch (ABI.BR) said.
13. Goldman, closer to Murdoch than Bugs Bunny, misses year’s biggest deal
It has been six years since Goldman Sachs Group Inc, a perennial No. 1 in the M&A league tables, did not feature as an adviser on the year’s biggest deal. But sticking with Rupert Murdoch over Bugs Bunny just cost it this year’s biggest deal.
Technology News
Meanwhile in Europ
The European banks are in much worse shape than their US competition. The reason being argued in Europe is that the US government imposed a ban on speculation
Today’s Economic Calendar
8:55 Redbook Chain Store Sales
9:00 FHFA House Price Index
9:00 S&P Case-Shiller Home Price Index
10:00 Consumer Confidence
10:00 Richmond Fed Mfg.
10:00 State Street Investor Confidence Index
1:00 PM Results of $26B, 2-Year Note Auction
1:20 PM Fed’s Lockhart speech
If you enjoy the content from SeekingOptions, please like our Facebook page and subscribe to our Youtube Channel